The Drug Enforcement Administration (DEA) slapped digital pharmacy and telehealth startup Truepill with an Order to Show Cause for unlawfully dispensing thousands of prescription stimulants used to treat ADHD, including Adderall.
The DEA alleges the online pharmacy filled more than 72,000 controlled substance prescriptions between September 2020 and September 2022, of which 60% were for...
Axios' Erin Brodwin published a new investigation which discovered healthcare automation startup Olive is exaggerating its capabilities and only uses "rough estimations" to gauge its cost savings. According to the report, Olive, which promises health systems cost savings, is only tracking savings if a client requests it. The report also highlighted Olive employees' concerns about how the company...
Truepill has tapped Sid Viswanathan as its next CEO. This news comes after the digital pharmacy announced a $142 million funding deal in October.
A cofounder of the company, Viswanathan started Truepill in 2016. Since then he served as the company's president. In this new position, he will handle day-to-day operations. He is taking over for fellow cofounder Umar Afridi, who will continue to have...
Qure.ai scored FDA 510(k) clearance for its artificial intelligence algorithm that assists providers in placing breathing tubes.
The clearance, which officially came down in late December, is the company's third 510(k). The two previous FDA green lights were regarding its brain CT scan product.
Using chest x-rays, the qXR-BT algorithm can analyze the position of the breathing tube. It automates...
Though COVID-19 vaccines began their rollout to the public, 2021 was still a turbulent year for healthcare providers as they weathered new virus variants, staffing shortages and burnout.
But the pandemic also created a new wave of interest in virtual care and telehealth. Many providers turned toward the modality to keep in contact with patients in 2020, but startups and other organizations are...
Digital health platform Truepill on Wednesday announced plans for a virtual care offering aimed at providing telehealth appointments and antiviral drugs for COVID-19.
The platform, which Truepill said will launch in the coming weeks, will include a patient portal to log COVID-19 test results and symptoms, telehealth consultations, antiviral medication prescriptions and overnight drug delivery or...
Digital health company Truepill scored $142 million in Series D financing from existing investors Initialized Capital and TI Platform Management.
The company said the new funding brings its total raise to $256 million and its valuation to $1.6 billion. Truepill announced a $75 million Series C in September 2020, just a few months after it brought in $25 million in Series B funding.
WHAT THEY DO...
Today there are still a lot of questions around getting the workforce back into the office, clinic or manufacturing site. Digital health company Truepill is looking to address this issue by teaming up with the Health Transformation Alliance to offer Truepill's new employer-focused suite of COVID-19-focused diagnostics and digital tools to the former's members.
Truepill's new program will...
Just two months after closing its Series B funding, Truepill, a digital pharmacy that focuses on APIs, telehealth practitioners and pharmacy fulfillment services, announced a new $75 million Series C funding round.
The funding, which will help kick off the company's at-home lab testing efforts, was led by Oak HC/FT with participation from Optum Ventures, TI Platform Management, Sound Ventures...
Kindbody, a women's health startup combining virtual care with face-to-face visits, raised $32 million in Series B funding. Perceptive Advisors led the round, which also saw support from prior backers RRE, GV and Freemark Capital, as well as new investors Rock Springs Capital, Goodgrower, Claritas Capital and NFP.
The startup said it would be using its new funding to expand its owned physical...
